Drug Profile


Alternative Names: BPC 15; BPC-157; PCO-02; PL 10; PLD 116; PLD 14736

Latest Information Update: 30 Dec 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Zagreb
  • Developer PharmaCotherapia; PLIVA d.d.
  • Class Anti-inflammatories; Antiallergics; Antiulcers; Cytoprotectives; Peptides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Ulcerative colitis

Most Recent Events

  • 01 Oct 2015 Phase-I clinical trials in Ulcerative colitis (In volunteers) in Mexico (PO) (NCT02637284)
  • 01 Jun 2005 Data presented at Digestive Disease Week-2005 (DDW-2005) have been added to the adverse events and Inflammatory bowel disorders therapeutic trials sections
  • 03 Dec 2003 A preclinical study has been added to the Peptic Ulcer Disease pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top